Abiopharma

Nagel Bradley M. 🟡 adjusted position in 14.5K shares (1 derivative) of Electromed, Inc. (ELMD) at $23.95 Transaction Date: Sep 02, 2025 | Filing ID: 028373

La plataforma Designed Enzymatic Biomaterials™ de IFF se utiliza a gran escala por primera vez en aplicaciones para el cuidado del hogar

Phreesia Investor Relations - Phreesia Announces Second Quarter Fiscal 2026 Results

New Form 3 - Sanara MedTech Inc. Filed: 2025-09-04 AccNo: 0001493152-25-012635 Size: 3 KB

GUGGENHIME ANDREW 🔴 sold 5.1K shares of Vaxcyte, Inc. (PCVX) at $31.56 Transaction Date: Sep 02, 2025 | Filing ID: 000007

Raykov Rosty 🔴 sold 10.0K shares of FENNEC PHARMACEUTICALS INC. (FENC) at $8.92 Transaction Date: Sep 04, 2025 | Filing ID: 023647

New Form 8-K - BOSTON SCIENTIFIC CORP Filed: 2025-09-04 AccNo: 0000885725-25-000043 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Director Cabral Timothy S 🔴 sold 6.4K shares of Doximity, Inc. (DOCS) at $66.30 Transaction Date: Sep 02, 2025 | Filing ID: 000007

Zimmer Biomet Holdings, Inc. Notification

New Form 8-K - Phreesia, Inc. Filed: 2025-09-04 AccNo: 0001412408-25-000058 Size: 8 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Director Wampler Kira Scherer 🟡 adjusted position in 2.0K shares (3 derivative) of Doximity, Inc. (DOCS) at $66.57 Transaction Date: Sep 02, 2025 | Filing ID: 000005

New Form 8-K - Theriva Biologics, Inc. Filed: 2025-09-04 AccNo: 0001104659-25-087465 Size: 233 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 8-K - iSpecimen Inc. Filed: 2025-09-04 AccNo: 0001213900-25-084497 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Replimune Group, Inc. Filed: 2025-09-04 AccNo: 0001104659-25-087464 Size: 224 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form S-8 - ClearPoint Neuro, Inc. Filed: 2025-09-04 AccNo: 0001285550-25-000014 Size: 466 KB